Thermo Fisher Scientific
TMO
1,543 hedge funds and large institutions have $105B invested in Thermo Fisher Scientific in 2019 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 562 increasing their positions, 626 reducing their positions, and 86 closing their positions.
16% more call options, than puts
Call options by funds: $365M | Put options by funds: $314M
0.07% more ownership
Funds ownership: 89.67% → 89.74% (+0.07%)
1% less capital invested
Capital invested by funds: $105B → $105B (-$559M)
7% less first-time investments, than exits
New positions opened: 80 | Existing positions closed: 86
1% less funds holding
Funds holding: 1,559 → 1,543 (-16)
10% less funds holding in top 10
Funds holding in top 10: 148 → 133 (-15)
10% less repeat investments, than reductions
Existing positions increased: 562 | Existing positions reduced: 626
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$709M |
| 2 |
UBS AM
Chicago,
Illinois
|
+$239M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
+$217M |
| 4 |
BlackRock
New York
|
+$193M |
| 5 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$179M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$237M |
| 2 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$159M |
| 3 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$153M |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$150M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$138M |
TMO Hedge Fund Activity: Q3 2019 in Review
1,543 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2019, worth a combined $105B — down 0.53% from $105B a quarter earlier.
Sellers outnumbered buyers: 86 funds closed out of TMO and 80 opened new positions — a net loss of 6 holders — while 626 trimmed existing stakes and 562 added.
The largest buyer was Morgan Stanley, adding an estimated $709M. The largest seller was Capital Research Global Investors, cutting an estimated $237M.
- 1,543 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2019, down from 1,559 in Q2 2019.
- Funds reported $105B of Thermo Fisher Scientific stock for Q3 2019, down 0.53% quarter-over-quarter.
- 80 funds opened new Thermo Fisher Scientific positions in Q3 2019 and 86 closed out, a net change of -6 holders.
- The largest Thermo Fisher Scientific buyer in Q3 2019 was Morgan Stanley, an estimated $709M added.
- The largest Thermo Fisher Scientific seller in Q3 2019 was Capital Research Global Investors, an estimated $237M sold.
Based on aggregated 13F filings for Q3 2019.